Reaching Consensus on the Adoption of Oncology Biosimilars

Learn from expert faculty what key clinical considerations inform the use of biosimilars in oncology practice with this series of ClinicalThought&trade commentaries!

Share

Program Content

Activities

Biosimilars vs Biologics
Insights on Developing and Evaluating Biosimilars for Cancer Care
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 14, 2018

Expires: November 13, 2019

Biosimilar Integration
Addressing Barriers to Biosimilar Integration in Cancer Care
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 18, 2018

Expires: December 17, 2019

Available Biosimilars
Biosimilar Updates for Supportive and Therapeutic Cancer Care
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 18, 2019

Expires: January 17, 2020

Provided by

ProCE Banner

Supporters

This activity is supported by an educational funding donation provided by

Amgen, Inc.